Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (31-40 of 361) with videos related to

Pageof 37
Sort By:
Nature Clinical Practice. Oncology|January 13, 2006
Clinical management of BRCA1 and BRCA2 mutation carriersSusan M Domchek, Katrina Armstrong, Barbara L Weber
Journal of the National Comprehensive Cancer Network : JNCCN|February 3, 2006
Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriersSusan M Domchek, Jill E Stopfer, Timothy R Rebbeck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2019
Reply to Patel and McLeodMadison K Kilbride, Susan M Domchek, Angela R Bradbury
Journal of the National Cancer Institute|December 17, 2019
CDH1 on Multigene Panel Testing: Look Before You LeapBryson W Katona, Dana Farengo Clark, Susan M Domchek
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Immunotherapy for Breast Cancer: What Are We Missing?Robert H Vonderheide, Susan M Domchek, Amy S Clark
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests?Madison K Kilbride, Susan M Domchek, Angela R Bradbury
Journal of the National Cancer Institute|May 15, 2014
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysisTara M Friebel, Susan M Domchek, Timothy R Rebbeck
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Refining Breast Cancer Risk Stratification: Additional Genes, Additional InformationAllison W Kurian, Antonis C Antoniou, Susan M Domchek
JAMA Oncology|July 21, 2018
Ethical Implications of Direct-to-Consumer Hereditary Cancer TestsMadison K Kilbride, Susan M Domchek, Angela R Bradbury
Journal of the National Cancer Institute|January 15, 2009
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriersTimothy R Rebbeck, Noah D Kauff, Susan M Domchek
Pageof 37

Showing results (31-40 of 361) with videos related to

Sort By:
Pageof 37
Nature Clinical Practice. Oncology|January 13, 2006
Clinical management of BRCA1 and BRCA2 mutation carriersSusan M Domchek, Katrina Armstrong, Barbara L Weber
Journal of the National Comprehensive Cancer Network : JNCCN|February 3, 2006
Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriersSusan M Domchek, Jill E Stopfer, Timothy R Rebbeck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2019
Reply to Patel and McLeodMadison K Kilbride, Susan M Domchek, Angela R Bradbury
Journal of the National Cancer Institute|December 17, 2019
CDH1 on Multigene Panel Testing: Look Before You LeapBryson W Katona, Dana Farengo Clark, Susan M Domchek
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Immunotherapy for Breast Cancer: What Are We Missing?Robert H Vonderheide, Susan M Domchek, Amy S Clark
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests?Madison K Kilbride, Susan M Domchek, Angela R Bradbury
Journal of the National Cancer Institute|May 15, 2014
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysisTara M Friebel, Susan M Domchek, Timothy R Rebbeck
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Refining Breast Cancer Risk Stratification: Additional Genes, Additional InformationAllison W Kurian, Antonis C Antoniou, Susan M Domchek
JAMA Oncology|July 21, 2018
Ethical Implications of Direct-to-Consumer Hereditary Cancer TestsMadison K Kilbride, Susan M Domchek, Angela R Bradbury
Journal of the National Cancer Institute|January 15, 2009
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriersTimothy R Rebbeck, Noah D Kauff, Susan M Domchek
Pageof 37